Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Blood|February 28, 2002
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)Jan Cools, Nicole Mentens, Maria D Odero, et al.
Open Research Europe|June 20, 2024
Deriving lessons learned from monitoring adaptation activities in projects under the EU mission on adaptationStephanie Bilgram, Carla Klusmann, Christian Kind, et al.
Blood|November 25, 2003
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJan Cools, Hilmar Quentmeier, Brian J P Huntly, et al.
Cancer Research|September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemiaJan Cools, Nicole Mentens, Pascal Furet, et al.
Water Research|July 10, 2024
Framework for mapping large-scale nature-based solutions for drought mitigation: Regional application in FlandersEstifanos Addisu Yimer, Lien De Trift, Stefaan Dondeyne, et al.
Oncogene|December 3, 2021
HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohortElyse C Page, Susan L Heatley, Laura N Eadie, et al.
Plos One|March 15, 2014
A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain sheddingNathalie Wojtalewicz, Elham Sadeqzadeh, Jakob V Weiß, et al.
Blood|July 17, 2004
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518Jennifer J Clark, Jan Cools, David P Curley, et al.
European Journal of Medicinal Chemistry|April 10, 2013
Identification of novel FLT3 kinase inhibitorsDaphnie Pauwels, Hugo Klaassen, Idoya Lahortiga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylateHans Prenen, Jan Cools, Nicole Mentens, et al.
Pageof 18